"Gene Rearrangement" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The ordered rearrangement of gene regions by DNA recombination such as that which occurs normally during development.
| Descriptor ID |
D015321
|
| MeSH Number(s) |
G05.344
|
| Concept/Terms |
Gene Rearrangement- Gene Rearrangement
- Gene Rearrangements
- Rearrangement, Gene
- Rearrangements, Gene
- DNA Rearrangement
- DNA Rearrangements
- Rearrangement, DNA
- Rearrangements, DNA
|
Below are MeSH descriptors whose meaning is more general than "Gene Rearrangement".
Below are MeSH descriptors whose meaning is more specific than "Gene Rearrangement".
This graph shows the total number of publications written about "Gene Rearrangement" by people in this website by year, and whether "Gene Rearrangement" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 1 | 3 | 4 |
| 1996 | 0 | 6 | 6 |
| 1997 | 1 | 3 | 4 |
| 1998 | 1 | 4 | 5 |
| 1999 | 1 | 2 | 3 |
| 2000 | 1 | 1 | 2 |
| 2001 | 1 | 0 | 1 |
| 2002 | 3 | 2 | 5 |
| 2003 | 1 | 1 | 2 |
| 2004 | 1 | 2 | 3 |
| 2005 | 1 | 1 | 2 |
| 2006 | 3 | 4 | 7 |
| 2007 | 3 | 3 | 6 |
| 2008 | 3 | 2 | 5 |
| 2009 | 9 | 6 | 15 |
| 2010 | 4 | 3 | 7 |
| 2011 | 7 | 3 | 10 |
| 2012 | 10 | 6 | 16 |
| 2013 | 1 | 3 | 4 |
| 2014 | 2 | 3 | 5 |
| 2015 | 3 | 7 | 10 |
| 2016 | 2 | 3 | 5 |
| 2017 | 0 | 3 | 3 |
| 2018 | 3 | 0 | 3 |
| 2019 | 2 | 4 | 6 |
| 2020 | 2 | 5 | 7 |
| 2021 | 2 | 2 | 4 |
| 2022 | 0 | 3 | 3 |
| 2023 | 0 | 1 | 1 |
| 2024 | 0 | 5 | 5 |
To return to the timeline,
click here.
Below are the most recent publications written about "Gene Rearrangement" by people in Profiles.
-
Co-targeting of the thymic stromal lymphopoietin receptor to decrease immunotherapeutic resistance in CRLF2-rearranged Ph-like and Down syndrome acute lymphoblastic leukemia. Leukemia. 2025 Mar; 39(3):555-567.
-
High-grade B-cell lymphomas: Double hit and non-double hit. Hum Pathol. 2025 Feb; 156:105700.
-
Cyclin D1-negative mantle cell lymphoma. Hum Pathol. 2025 Feb; 156:105698.
-
Integrative immunophenotypic and genetic characterization of acute myeloid leukemia with CBFB rearrangement. Am J Clin Pathol. 2024 Nov 04; 162(5):455-463.
-
Long-read sequencing of an advanced cancer cohort resolves rearrangements, unravels haplotypes, and reveals methylation landscapes. Cell Genom. 2024 Nov 13; 4(11):100674.
-
Biologic and Clinical Analysis of Childhood Gamma Delta T-ALL Identifies LMO2/STAG2 Rearrangements as Extremely High Risk. Cancer Discov. 2024 Oct 04; 14(10):1838-1859.
-
Selective inhibition of HDAC class IIA as therapeutic intervention for KMT2A-rearranged acute lymphoblastic leukemia. Commun Biol. 2024 Oct 04; 7(1):1257.
-
Genomic Balancing Act: deciphering DNA rearrangements in the complex chromosomal aberration involving 5p15.2, 2q31.1, and 18q21.32. Eur J Hum Genet. 2025 Mar; 33(2):231-238.
-
Myoepithelial tumors of soft tissue and bone in children and young adults: A clinicopathologic study of 40 cases occurring in patients = 21?Years of age. Hum Pathol. 2024 07; 149:10-20.
-
Outcome of 3q26.2/MECOM rearrangements in chronic myeloid leukemia. Int J Hematol. 2024 Aug; 120(2):203-211.